ObsEva SA announced the resignation of Jean-Pierre Gotteland, Chief Scientific Officer and Head of Research & Development, effective September 30, 2022. Dr. Gotteland will step down from the Company's Executive Committee, effective immediately.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | 0.00% |
|
0.00% | -100.00% |
2023 | ObsEva to Suspend Reporting With SEC Following Delisting From Nasdaq | MT |
2023 | ObsEva to Change Central Securities Depositary to SIX SIS; Shares Up 9% | MT |
1st Jan change | Capi. | |
---|---|---|
-100.00% | 117 | |
+16.61% | 12TCr | |
+17.75% | 11TCr | |
+17.23% | 2.59TCr | |
-24.11% | 1.93TCr | |
-18.56% | 1.62TCr | |
-18.47% | 1.56TCr | |
-47.75% | 1.46TCr | |
+57.35% | 1.43TCr | |
+5.62% | 1.4TCr |
- Stock Market
- Equities
- OBSEF Stock
- News ObsEva SA
- ObsEva SA Announces Management Change